Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 976

1.

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.

Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G.

Lancet Respir Med. 2020 Feb 14. pii: S2213-2600(19)30372-8. doi: 10.1016/S2213-2600(19)30372-8. [Epub ahead of print]

PMID:
32066536
2.

[Management of right ventricular failure in pulmonary vascular diseases].

Boucly A, Savale L, Vuillard C, Turpin M, Jaïs X, Montani D, Humbert M, Sitbon O.

Rev Mal Respir. 2020 Feb 12. pii: S0761-8425(19)31084-8. doi: 10.1016/j.rmr.2019.07.012. [Epub ahead of print] Review. French.

PMID:
32061440
3.

Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.

Knafl D, Gerges C, King CH, Humbert M, Bustinduy AL.

Eur Respir Rev. 2020 Feb 5;29(155). pii: 190089. doi: 10.1183/16000617.0089-2019. Print 2020 Mar 31. Review.

4.

Preoperative C-reactive protein predicts early postoperative outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.

Arthur Ataam J, Amsallem M, Guihaire J, Haddad F, Lamrani L, Stephan F, Jaïs X, Humbert M, Mercier O, Fadel E.

J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43490-9. doi: 10.1016/j.jtcvs.2019.11.133. [Epub ahead of print]

PMID:
32007254
5.

Staphylococcus aureus and its IgE-inducing Enterotoxins in Asthma: Current Knowledge.

Bachert C, Humbert M, Hanania NA, Zhang N, Holgate S, Buhl R, Bröker BM.

Eur Respir J. 2020 Jan 24. pii: 1901592. doi: 10.1183/13993003.01592-2019. [Epub ahead of print]

PMID:
31980492
6.

Familial pulmonary arterial hypertension by KDR heterozygous loss of function.

Eyries M, Montani D, Girerd B, Favrolt N, Riou M, Faivre L, Manaud G, Perros F, Gräf S, Morrell NW, Humbert M, Soubrier F.

Eur Respir J. 2020 Jan 24. pii: 1902165. doi: 10.1183/13993003.02165-2019. [Epub ahead of print]

PMID:
31980491
7.

Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension.

Bordenave J, Tu L, Berrebeh N, Thuillet R, Cumont A, Le Vely B, Fadel E, Nadaud S, Savale L, Humbert M, Huertas A, Guignabert C.

Arterioscler Thromb Vasc Biol. 2020 Jan 23:ATVBAHA119313715. doi: 10.1161/ATVBAHA.119.313715. [Epub ahead of print]

PMID:
31969018
8.

The role of growth and maturation during adolescence on team-selection and short-term sports participation.

Baxter-Jones ADG, Barbour-Tuck EN, Dale D, Sherar LB, Knight CJ, Cumming SP, Ferguson LJ, Kowalski KC, Humbert ML.

Ann Hum Biol. 2020 Jan 21:1-8. doi: 10.1080/03014460.2019.1707870. [Epub ahead of print]

PMID:
31960720
9.

Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.

Antigny F, Mercier O, Humbert M, Sabourin J.

Arch Cardiovasc Dis. 2020 Jan;113(1):70-84. doi: 10.1016/j.acvd.2019.10.009. Epub 2020 Jan 8. Review.

PMID:
31924541
10.

Atypical, Yet Not Infrequent, Infections with Neisseria Species.

Humbert MV, Christodoulides M.

Pathogens. 2019 Dec 20;9(1). pii: E10. doi: 10.3390/pathogens9010010. Review.

11.

Screening strategies for pulmonary arterial hypertension.

Kiely DG, Lawrie A, Humbert M.

Eur Heart J Suppl. 2019 Dec;21(Suppl K):K9-K20. doi: 10.1093/eurheartj/suz204. Epub 2019 Dec 17.

12.

Pulmonary arterial hypertension registries: past, present and into the future.

Weatherald J, Reis A, Sitbon O, Humbert M.

Eur Respir Rev. 2019 Dec 18;28(154). pii: 190128. doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31. No abstract available.

13.

Novel ADGRG2 truncating variants in patients with X-linked congenital absence of vas deferens.

Pagin A, Bergougnoux A, Girodon E, Reboul MP, Willoquaux C, Kesteloot M, Raynal C, Bienvenu T, Humbert M, Lalau G, Bieth E.

Andrology. 2019 Dec 17. doi: 10.1111/andr.12744. [Epub ahead of print]

PMID:
31845523
14.

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.

Jackson DJ, Humbert M, Hirsch I, Newbold P, Garcia Gil E.

Adv Ther. 2020 Feb;37(2):718-729. doi: 10.1007/s12325-019-01191-2. Epub 2019 Dec 14.

PMID:
31836949
15.

Chronic Inflammation Within the Vascular Wall in Pulmonary Arterial Hypertension: More than a Spectator.

Huertas A, Tu L, Humbert M, Guignabert C.

Cardiovasc Res. 2019 Nov 14. pii: cvz308. doi: 10.1093/cvr/cvz308. [Epub ahead of print]

PMID:
31813986
16.

Rebuttal From Drs Humbert and Lau.

Humbert M, Lau EMT.

Chest. 2019 Dec;156(6):1045-1046. doi: 10.1016/j.chest.2019.07.003. No abstract available.

PMID:
31812190
17.

POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes.

Humbert M, Lau EMT.

Chest. 2019 Dec;156(6):1039-1042. doi: 10.1016/j.chest.2019.07.005. No abstract available.

PMID:
31812188
18.

Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.

Boucly A, Morélot-Panzini C, Garcia G, Weatherald J, Jaïs X, Savale L, Montani D, Humbert M, Similowski T, Sitbon O, Laveneziana P.

Eur Respir J. 2020 Feb 12;55(2). pii: 1802108. doi: 10.1183/13993003.02108-2018. Print 2020 Feb.

PMID:
31771998
19.

Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma.

Busse WW, Humbert M, Haselkorn T, Ortiz B, Trzaskoma BL, Stephenson P, Garcia Conde L, Kianifard F, Holgate ST.

Ann Allergy Asthma Immunol. 2020 Feb;124(2):190-196. doi: 10.1016/j.anai.2019.11.016. Epub 2019 Nov 22.

20.

Survival Improved in Patients Aged ≤ 70 Years With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension During the Period 2006 to 2017 in France.

Hachulla E, Launay D, Boucly A, Mouthon L, de Groote P, Cottin V, Pugnet G, Prévôt G, Bourlier D, Dauphin C, Chaouat A, Weatherald J, Simonneau G, Montani D, Humbert M, Sitbon O, Giovannelli J.

Chest. 2019 Nov 19. pii: S0012-3692(19)34216-3. doi: 10.1016/j.chest.2019.10.045. [Epub ahead of print]

21.

Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension.

Ulrich A, Wharton J, Thayer TE, Swietlik EM, Assad TR, Desai AA, Gräf S, Harbaum L, Humbert M, Morrell NW, Nichols WC, Soubrier F, Southgate L, Trégouët DA, Trembath RC, Brittain EL, Wilkins MR, Prokopenko I, Rhodes CJ; NIHR BioResource – Rare Diseases Consortium; UK PAH Cohort Study Consortium; and the US PAH Biobank Consortium.

Eur Respir J. 2020 Feb 12;55(2). pii: 1901486. doi: 10.1183/13993003.01486-2019. Print 2020 Feb.

22.

[Vertebroplasty in elderly patients : is less still too much ?]

Félix S, Humbert M, Büla C, Lamy O.

Rev Med Suisse. 2019 Nov 6;15(670):2027-2031. Review. French.

PMID:
31696677
23.

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.

Adams O, Janser FA, Dislich B, Berezowska S, Humbert M, Seiler CA, Kröll D, Slotta-Huspenina J, Feith M, Ott K, Tschan MP, Langer R.

PLoS One. 2019 Oct 30;14(10):e0224832. doi: 10.1371/journal.pone.0224832. eCollection 2019.

24.

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M, Southgate L, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, Lawrie A, MacKenzie Ross RV, Moledina S, Montani D, Olschewski A, Olschewski H, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Trembath RC, Vonk Noordegraaf A, Wort SJ, Wilkins MR, Yu PB, Li W, Gräf S, Upton PD, Morrell NW.

Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1141OC. [Epub ahead of print]

PMID:
31661308
25.

A roadmap for management of chronic thromboembolic pulmonary hypertension.

Jaïs X, Brenot P, Montani D, Fadel E, Humbert M, Simonneau G.

Eur Respir J. 2019 Oct 24;54(4). pii: 1901295. doi: 10.1183/13993003.01295-2019. Print 2019 Oct. No abstract available.

PMID:
31649145
26.

Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma.

Nair P, Bardin P, Humbert M, Murphy KR, Hickey L, Garin M, Vanlandingham R, Chanez P.

J Allergy Clin Immunol Pract. 2020 Feb;8(2):555-564. doi: 10.1016/j.jaip.2019.09.036. Epub 2019 Oct 15.

27.

Rare pulmonary disease and orphan drugs: a path to the future.

Harari S, Adir Y, Humbert M.

Eur Respir Rev. 2019 Oct 1;28(153). pii: 190115. doi: 10.1183/16000617.0115-2019. Print 2019 Sep 30. No abstract available.

28.

Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension.

Seferian A, Jaïs X, Savale L, Jevnikar M, Ghigna MR, Weatherald J, Assoun S, Fadel E, Simonneau G, Sitbon O, Humbert M, Montani D.

Respir Med Res. 2019 Nov;76:48-53. doi: 10.1016/j.resmer.2019.06.002. Epub 2019 Jul 9.

PMID:
31557688
29.

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.

Savale L, Habibi A, Lionnet F, Maitre B, Cottin V, Jais X, Chaouat A, Artaud-Macari E, Canuet M, Prevot G, Chantalat-Auger C, Montani D, Sitbon O, Galacteros F, Simonneau G, Parent F, Bartolucci P, Humbert M.

Eur Respir J. 2019 Dec 4;54(6). pii: 1900585. doi: 10.1183/13993003.00585-2019. Print 2019 Dec. Erratum in: Eur Respir J. 2020 Jan 30;55(1):.

PMID:
31537700
30.

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension.

Sanges S, Savale L, Lamblin N, Rémy-Jardin M, Humbert M, Sobanski V.

ESC Heart Fail. 2019 Dec;6(6):1322-1325. doi: 10.1002/ehf2.12507. Epub 2019 Sep 19.

31.

Hospital burden of pulmonary arterial hypertension in France.

Bergot E, De Leotoing L, Bendjenana H, Tournier C, Vainchtock A, Nachbaur G, Humbert M.

PLoS One. 2019 Sep 19;14(9):e0221211. doi: 10.1371/journal.pone.0221211. eCollection 2019.

32.

A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism.

Jones C, Bisserier M, Bueno-Beti C, Bonnet G, Neves-Zaph S, Lee SY, Milara J, Dorfmüller P, Humbert M, Leopold JA, Hadri L, Hajjar RJ, Sassi Y.

Cardiovasc Res. 2019 Sep 14. pii: cvz244. doi: 10.1093/cvr/cvz244. [Epub ahead of print]

PMID:
31529026
33.

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use.

Albers FC, Hozawa S, Bratton DJ, Yancey SW, Prazma CM, Humbert M, Liu MC.

Allergy. 2019 Sep 14. doi: 10.1111/all.14048. [Epub ahead of print] No abstract available.

PMID:
31520471
34.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Bousquet JJ, Schünemann HJ, Togias A, Erhola M, Hellings PW, Zuberbier T, Agache I, Ansotegui IJ, Anto JM, Bachert C, Becker S, Bedolla-Barajas M, Bewick M, Bosnic-Anticevich S, Bosse I, Boulet LP, Bourrez JM, Brusselle G, Chavannes N, Costa E, Cruz AA, Czarlewski W, Fokkens WJ, Fonseca JA, Gaga M, Haahtela T, Illario M, Klimek L, Kuna P, Kvedariene V, Le LTT, Larenas-Linnemann D, Laune D, Lourenço OM, Menditto E, Mullol J, Okamoto Y, Papadopoulos N, Pham-Thi N, Picard R, Pinnock H, Roche N, Roller-Wirnsberger RE, Rolland C, Samolinski B, Sheikh A, Toppila-Salmi S, Tsiligianni I, Valiulis A, Valovirta E, Vasankari T, Ventura MT, Walker S, Williams S, Akdis CA, Annesi-Maesano I, Arnavielhe S, Basagana X, Bateman E, Bedbrook A, Bennoor KS, Benveniste S, Bergmann KC, Bialek S, Billo N, Bindslev-Jensen C, Bjermer L, Blain H, Bonini M, Bonniaud P, Bouchard J, Briedis V, Brightling CE, Brozek J, Buhl R, Buonaiuto R, Canonica GW, Cardona V, Carriazo AM, Carr W, Cartier C, Casale T, Cecchi L, Cepeda Sarabia AM, Chkhartishvili E, Chu DK, Cingi C, Colgan E, de Sousa JC, Courbis AL, Custovic A, Cvetkosvki B, D'Amato G, da Silva J, Dantas C, Dokic D, Dauvilliers Y, Dedeu A, De Feo G, Devillier P, Di Capua S, Dykewickz M, Dubakiene R, Ebisawa M, El-Gamal Y, Eller E, Emuzyte R, Farrell J, Fink-Wagner A, Fiocchi A, Fontaine JF, Gemicioğlu B, Schmid-Grendelmeir P, Gamkrelidze A, Garcia-Aymerich J, Gomez M, González Diaz S, Gotua M, Guldemond NA, Guzmán MA, Hajjam J, O'B Hourihane J, Humbert M, Iaccarino G, Ierodiakonou D, Illario M, Ivancevich JC, Joos G, Jung KS, Jutel M, Kaidashev I, Kalayci O, Kardas P, Keil T, Khaitov M, Khaltaev N, Kleine-Tebbe J, Kowalski ML, Kritikos V, Kull I, Leonardini L, Lieberman P, Lipworth B, Lodrup Carlsen KC, Loureiro CC, Louis R, Mair A, Marien G, Mahboub B, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu-Dupas E, Matricardi PM, Melén E, Melo-Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica-Martinez MD, Mohammad Y, Montefort S, Monti R, Morais-Almeida M, Mösges R, Münter L, Muraro A, Murray R, Naclerio R, Napoli L, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Novellino E, Nyembue D, O'Hehir R, Ohta K, Okubo K, Onorato G, Ouedraogo S, Pali-Schöll I, Palkonen S, Panzner P, Park HS, Pépin JL, Pereira AM, Pfaar O, Paulino E, Phillips J, Picard R, Plavec D, Popov TA, Portejoie F, Price D, Prokopakis EP, Pugin B, Raciborski F, Rajabian-Söderlund R, Reitsma S, Rodo X, Romano A, Rosario N, Rottem M, Ryan D, Salimäki J, Sanchez-Borges MM, Sisul JC, Solé D, Somekh D, Sooronbaev T, Sova M, Spranger O, Stellato C, Stelmach R, Suppli Ulrik C, Thibaudon M, To T, Todo-Bom A, Tomazic PV, Valero AA, Valenta R, Valentin-Rostan M, van der Kleij R, Vandenplas O, Vezzani G, Viart F, Viegi G, Wallace D, Wagenmann M, Wang Y, Waserman S, Wickman M, Williams DM, Wong G, Wroczynski P, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zeng S, Zernotti M, Zhang L, Zhong NS, Zidarn M; ARIA Study Group; MASK Study Group.

Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Review.

35.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; ESC Scientific Document Group .

Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405. No abstract available.

PMID:
31504429
36.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Áinle FN, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Eur Respir J. 2019 Oct 9;54(3). pii: 1901647. doi: 10.1183/13993003.01647-2019. Print 2019 Sep. No abstract available.

PMID:
31473594
37.

Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.

Tian W, Jiang X, Sung YK, Shuffle E, Wu TH, Kao PN, Tu AB, Dorfmüller P, Cao A, Wang L, Peng G, Kim Y, Zhang P, Chappell J, Pasupneti S, Dahms P, Maguire P, Chaib H, Zamanian R, Peters-Golden M, Snyder MP, Voelkel NF, Humbert M, Rabinovitch M, Nicolls MR.

Circulation. 2019 Oct 22;140(17):1409-1425. doi: 10.1161/CIRCULATIONAHA.119.040629. Epub 2019 Aug 29.

PMID:
31462075
38.

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.

Khurana S, Brusselle GG, Bel EH, FitzGerald JM, Masoli M, Korn S, Kato M, Albers FC, Bradford ES, Gilson MJ, Price RG, Humbert M.

Clin Ther. 2019 Oct;41(10):2041-2056.e5. doi: 10.1016/j.clinthera.2019.07.007. Epub 2019 Aug 22.

39.

A rapid diagnostic test for human Visceral Leishmaniasis using novel Leishmania antigens in a Laser Direct-Write Lateral Flow Device.

Humbert MV, Costa LE, Katis I, Fonseca Ramos F, Sanchéz Machado A, Sones C, Ferraz Coelho EA, Christodoulides M.

Emerg Microbes Infect. 2019;8(1):1178-1185. doi: 10.1080/22221751.2019.1635430.

40.

Screening for pulmonary arterial hypertension in systemic sclerosis.

Weatherald J, Montani D, Jevnikar M, Jaïs X, Savale L, Humbert M.

Eur Respir Rev. 2019 Jul 31;28(153). pii: 190023. doi: 10.1183/16000617.0023-2019. Print 2019 Sep 30.

41.

Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.

Lambert M, Capuano V, Boet A, Tesson L, Bertero T, Nakhleh MK, Remy S, Anegon I, Pechoux C, Hautefort A, Rucker-Martin C, Manoury B, Domergue V, Mercier O, Girerd B, Montani D, Perros F, Humbert M, Antigny F.

Circ Res. 2019 Sep 13;125(7):678-695. doi: 10.1161/CIRCRESAHA.119.314793. Epub 2019 Jul 26.

PMID:
31347976
42.

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.

Perros F, Sentenac P, Boulate D, Manaud G, Kotsimbos T, Lecerf F, Lamrani L, Fadel E, Mercier O, Londono-Vallejo A, Humbert M, Eddahibi S.

Int J Mol Sci. 2019 Jul 22;20(14). pii: E3575. doi: 10.3390/ijms20143575.

43.

Outpatient management of patients with low-risk pulmonary embolism: another piece of evidence.

Sanchez O, Humbert M.

Eur Heart J. 2020 Jan 21;41(4):519-521. doi: 10.1093/eurheartj/ehz484. No abstract available.

PMID:
31302693
44.

Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Humbert MV, Jackson A, Orr CM, Tews I, Christodoulides M.

Sci Rep. 2019 Jul 11;9(1):10055. doi: 10.1038/s41598-019-46506-z.

45.

Severe T2-high asthma in the biologics era: European experts' opinion.

Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190054. doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30. Review.

46.

High Glass-Transition Temperature Polymer Networks Harnessing the Dynamic Ring Opening of Pinacol Boronates.

Brunet J, Collas F, Humbert M, Perrin L, Brunel F, Lacôte E, Montarnal D, Raynaud J.

Angew Chem Int Ed Engl. 2019 Aug 26;58(35):12216-12222. doi: 10.1002/anie.201904559. Epub 2019 Jul 25. Review.

PMID:
31241821
47.

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.

Humbert M, Albers FC, Bratton DJ, Yancey SW, Liu MC, Hozawa S, Llanos JP, Kwon N.

Respir Med. 2019 Jul - Aug;154:69-75. doi: 10.1016/j.rmed.2019.06.004. Epub 2019 Jun 8.

PMID:
31220806
48.

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C.

Cardiovasc Res. 2020 Mar 1;116(3):686-697. doi: 10.1093/cvr/cvz153.

PMID:
31173066
49.

Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.

Antigny F, Chaumais MC, Humbert M, Montani D.

Fundam Clin Pharmacol. 2019 Aug;33(4):426-427. doi: 10.1111/fcp.12489. Epub 2019 Jun 26. No abstract available.

PMID:
31148228
50.

Cloning, Expression, and Purification of Recombinant Neisseria gonorrhoeae Proteins.

Humbert MV.

Methods Mol Biol. 2019;1997:233-266. doi: 10.1007/978-1-4939-9496-0_15.

PMID:
31119628

Supplemental Content

Loading ...
Support Center